Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins

Immunotherapy, Ahead of Print.

Source: Immunotherapy - September 8, 2020 Category: Allergy & Immunology Authors: Jos é María Díez Carolina Romero J úlia Vergara-Alert Melissa Bell ó-Perez Jordi Rodon Jos é Manuel Honrubia Joaquim Segal és Isabel Sola Luis Enjuanes Rodrigo Gajardo Source Type: research